Enhancing metabolomics research through data mining

Journal of Proteomics

Volumn 127, Issue , 2015, Pages 275-288

  Martínez Arranz, Ibon ^a   Mayo, Rebeca ^a   Pérez Cormenzana, Miriam ^a   Mincholé, Itziar ^a   Salazar, Lorena ^b   Alonso, Cristina ^a   Mato, José M ^c  

^a OWL Genomics   (Spain)

^b Osarten kooperatiba elkartea   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Aging; Inter batch normalization; Linear regression; MANOVA; Metabolomics; Statistical assumptions

Indexed keywords

ADULT; AGING; ARTICLE; DATA MINING; DATA PROCESSING; FEMALE; HUMAN; HUMAN CELL; LINEAR REGRESSION ANALYSIS; MALE; METABOLOMICS; MULTIVARIATE ANALYSIS; MULTIVARIATE ANALYSIS OF VARIANCE; NORMAL HUMAN; PRIORITY JOURNAL; UNIVARIATE ANALYSIS; PROCEDURES;

DATA MINING; METABOLOMICS;

EID: 84944155380     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2015.01.019     Document Type: Article

References (64)

1. Nicholson J.K., Lindon J.C. Systems biology: metabonomics. Nature 2008, 455(7216):1054-1056.
2. Goodacre R., Vaidyanathan S., Dunn W.B., Harrigan G.G., Kell D.B. Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol 2004, 22(5):245-252.
3. Baker M. Metabolomics: from small molecules to big ideas. Nat Methods 2011, 8(2):117-121.
4. Chiarugi A., Dölle C., Felici R., Ziegler M. The NAD metabolome-a key determinant of cancer cell biology. Nat Rev Cancer 2012, 12(11):741-752.
5. Cuperlović-Culf M., Barnett D.A., Culf A.S., Chute I. Cell culture metabolomics: applications and future directions. Drug Discov Today 2010, 15(15-16):610-621.
6. DeBerardinis R.J., Thompson C.B. Cellular metabolism and disease: what do metabolic outliers teach us?. Cell 2012, 148(6):1132-1144.
7. Halama A., Riesen N., Möller G., Hrabě de Angelis M., Adamski J. Identification of biomarkers for apoptosis in cancer cell lines using metabolomics: tools for individualized medicine. J Intern Med 2013, 274(5):425-439.
8. van Vliet E., Morath S., Eskes C., Linge J., Rappsilber J., Honegger P., et al. A novel in vitro metabolomics approach for neurotoxicity testing, proof of principle for methyl mercury chloride and caffeine. Neurotoxicology 2008, 29(1):1-12.
9. Spagou K., Wilson I.D., Masson P., Theodoridis G., Raikos N., Coen M., et al. HILIC-UPLC-MS for exploratory urinary metabolic profiling in toxicological studies. Anal Chem 2011, 83(1):382-390.
10. Herrero M., Simó C., García-Cañas V., Ibáñez E., Cifuentes A. Foodomics: MS-based strategies in modern food science and nutrition. Mass Spectrom Rev 2012, 31(1):49-69.
11. Scalbert A., Brennan L., Manach C., Andres-Lacueva C., Dragsted L.O., Draper J., et al. The food metabolome: a window over dietary exposure. Am J Clin Nutr 2014, 99(6):1286-1308.
12. Wishart D.S. Metabolomics: applications to food science and nutrition research. Trends Food Sci Technol 2008, 19(9):482-493.
13. Spratlin J.L., Serkova N.J., Eckhardt S.G. Clinical applications of metabolomics in oncology: a review. Clin Cancer Res 2009, 15(2):431-440.
14. Armitage E.G., Barbas C. Metabolomics in cancer biomarker discovery: current trends and future perspectives. J Pharm Biomed Anal 2014, 87:1-11.
15. Folger O., Jerby L., Frezza C., Gottlieb E., Ruppin E., Shlomi T. Predicting selective drug targets in cancer through metabolic networks. Mol Syst Biol 2011, 7:501.
16. Xia J., Broadhurst D.I., Wilson M., Wishart D.S. Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics 2013, 9(2):280-299.
17. Wheelock C.E., Goss V.M., Balgoma D., Nicholas B., Brandsma J., Skipp P.J., et al. Application of 'omics technologies to biomarker discovery in inflammatory lung diseases. Eur Respir J 2013, 42(3):802-825.
18. Smolinska A., Blanchet L., Buydens L.M.C., Wijmenga S.S. NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review. Anal Chim Acta 2012, 750:82-97.
19. Mamas M., Dunn W.B., Neyses L., Goodacre R. The role of metabolites and metabolomics in clinically applicable biomarkers of disease. Arch Toxicol 2011, 85(1):5-17.
20. Wang T.J., Larson M.G., Vasan R.S., Cheng S., Rhee E.P., McCabe E., et al. Metabolite profiles and the risk of developing diabetes. Nat Med 2011, 17(4):448-453.
21. Suhre K., Meisinger C., Döring A., Altmaier E., Belcredi P., Gieger C., et al. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One 2010, 5(11):e13953.
22. Kim O.Y., Lee J.H., Sweeney G. Metabolomic profiling as a useful tool for diagnosis and treatment of chronic disease: focus on obesity, diabetes and cardiovascular diseases. Expert Rev Cardiovasc Ther 2013, 11(1):61-68.
23. Trushina E., Mielke M.M. Recent advances in the application of metabolomics to Alzheimer's disease. Biochim Biophys Acta 2014, 1842(8):1232-1239.
24. Cano A., Alonso C. Deciphering non-alcoholic fatty liver disease through metabolomics. Biochem Soc Trans 2014, 42(5):1447-1452.
25. Lenz E.M., Wilson I.D. Analytical strategies in metabonomics. J Proteome Res 2007, 6(2):443-458.
26. Gowda G.A.N., Djukovic D. Overview of mass spectrometry-based metabolomics: opportunities and challenges. Methods Mol Biol 2014, 1198:3-12.
27. Scalbert A., Brennan L., Fiehn O., Hankemeier T., Kristal B.S., van Ommen B., et al. Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics 2009, 5(4):435-458.
28. Want E.J., Nordström A., Morita H., Siuzdak G. From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics. J Proteome Res 2007, 6(2):459-468.
29. Want E.J., Masson P., Michopoulos F., Wilson I.D., Theodoridis G., Plumb R.S., et al. Global metabolic profiling of animal and human tissues via UPLC-MS. Nat Protoc 2012, 8(1):17-32.
30. Dunn W.B., Broadhurst D., Begley P., Zelena E., Francis-McIntyre S., Anderson N., et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc 2011, 6(7):1060-1083.
31. Sumner L.W., Amberg A., Barrett D., Beale M.H., Beger R., Daykin C.A., et al. Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 2007, 3(3):211-221.
32. Goodacre R., Broadhurst D., Smilde A.K., Kristal B.S., Baker J.D., Beger R., et al. Proposed minimum reporting standards for data analysis in metabolomics. Metabolomics 2007, 3(3):231-241.
33. Salek R.M., Steinbeck C., Viant M.R., Goodacre R., Dunn W.B. The role of reporting standards for metabolite annotation and identification in metabolomic studies. GigaScience 2013, 2(1):13.
34. Barr J., Caballería J., Martínez-Arranz I., Domínguez-Díez A., Alonso C., Muntané J., et al. Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression. J Proteome Res 2012, 11(4):2521-2532.
35. van der Kloet F.M., Bobeldijk I., Verheij E.R., Jellema R.H. Analytical error reduction using single point calibration for accurate and precise metabolomic phenotyping. J Proteome Res 2009, 8(11):5132-5141.
36. Barr J., Vázquez-Chantada M., Alonso C., Pérez-Cormenzana M., Mayo R., Galán A., et al. Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. J Proteome Res 2010, 9(9):4501-4512.
37. Martínez-Arranz I., Mayo R., Pérez-Cormenzana M., Mincholé I., Salazar L., Alonso C., et al. Data in support of enhancing metabolomics research through data mining. Data in Brief 2015, [submitted for publication].
38. Engel J., Gerretzen J., Szymanska E., Jansen J.J., Downey G., Blanchet L., et al. Breaking with trends in pre-processing?. Trends Anal Chem. (TrAC) 2013, 50:96-106.
39. van den Berg R.A., Hoefsloot H.C.J., Westerhuis J.A., Smilde A.K., van der Werf M.J. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 2006, 7:142.
40. Sugimoto M., Kawakami M., Robert M., Soga T., Tomita M. Bioinformatics tools for mass spectroscopy-based metabolomic data processing and analysis. Curr Bioinform 2012, 7(1):96-108.
41. Katajamaa M., Oresic M. Processing methods for differential analysis of LC/MS profile data. BMC Bioinformatics 2005, 6:179.
42. Hrydziuszko O., Viant M. Missing values in mass spectrometry based metabolomics: an undervalued step in the data processing pipeline. Metabolomics 2012, 8(1):161-174.
43. Hair J.F., Black W.C., Babin B.J., Anderson R.E. Multivariate data analysis (7th edition) 2009, Prentice Hall. 7th ed.
44. Baraldi A.N., Enders C.K. An introduction to modern missing data analyses. J Sch Psychol 2010, 48(1):5-37.
45. Graham J.W. Missing data analysis: making it work in the real world. Annu Rev Psychol 2009, 60:549-576.
46. Henderson A.R. Testing experimental data for univariate normality. Clin Chim Acta 2006, 366(1-2):112-129.
47. Box G.E.P., Cox D.R. An analysis of transformations. J R Stat Soc Ser B Methodol 1964, 26(2):211-252.
48. Box G.E.P., Cox D.R. An analysis of transformations revisited, rebutted. J Am Stat Assoc 1982, 77(377):209-210.
49. Snecdecor G.W., Cochran W.G. Statistical methods 1991, Wiley.
50. Mansfield E.R., Helms B.P. Detecting multicollinearity. Am Stat 1982, 36(3a):158-160.
51. Alin A. Multicollinearity. Wiley Interdiscip Rev Comput Stat 2010, 2(3):370-374.
52. Miles J. Tolerance and variance inflation factor. Encyclopedia of statistics in behavioral science 2005, John Wiley & Sons, Ltd.
53. Varmuza K., Filzmoser P. Introduction to multivariate statistical analysis in chemometrics 2009, Taylor & Francis.
54. Royston J.P. Some techniques for assessing multivarate normality based on the Shapiro-Wilk W. J R Stat Soc Ser C Appl Stat 1983, 32(2):121-133.
55. Royston J.P. Approximating the Shapiro-Wilk W-test for non-normality. Stat Comput 1992, 2(3):117-119.
56. BOX G.E.P. A general distribution theory for a class of likelihood criteria. Biometrika 1949, 36(3-4):317-346.
57. Bray J.H., Maxwell S.E. Multivariate analysis of variance. Sage University Paper series on qualitative research methods 1985, Sage, Newbury Park.
58. Hand D.J., Taylor C.C. Multivariate analysis of variance and repeated measures: a practical approach for behavioural scientists 1987, Taylor & Francis.
59. Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19(2):185-193.
60. Cutler R.G., Mattson M.P. Sphingomyelin and ceramide as regulators of development and lifespan. Mech Ageing Dev 2001, 122(9):895-908.
61. Baylis D., Bartlett D.B., Patel H.P., Roberts H.C. Understanding how we age: insights into inflammaging. Longev Healthspan 2013, 2(1):8.
62. Mayo W., George O., Darbra S., Bouyer J.J., Vallée M., Darnaudéry M., et al. Individual differences in cognitive aging: implication of pregnenolone sulfate. Prog Neurobiol 2003, 71(1):43-48.
63. Morley J.E., Kaiser F., Raum W.J., Perry H.M., Flood J.F., Jensen J., et al. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. Proc Natl Acad Sci 1997, 94(14):7537-7542.
64. Hildebrandt W., Kinscherf R., Hauer K., Holm E., Dröge W. Plasma cystine concentration and redox state in aging and physical exercise. Mech Ageing Dev 2002, 123(9):1269-1281.